Rockley’s unique sensing platform enables continuous health and wellness monitoring of multiple biomarkers, paving the way for the next generation of consumer wearables and medical devices.

Transaction will advance the commercial launch of Rockley’s transformational monitoring sensors and the development of commercial opportunities in personal health, medtech and beyond.

Transaction values Rockley at a pro forma enterprise value of $1.2 billion.

Transaction includes a fully committed $150 million PIPE, with participation from top-tier institutional investors including Senvest Management LLC and UBS O’Connor and participation from Medtronic.

Founder Dr. Andrew Rickman, a pioneer in silicon photonics, will remain as CEO and Chairman

Click to download the complete press release.

With the flexibility and power of an innovative platform that drives multiple applications, Rockley is positioned to be the leading supplier of integrated optical components for dynamic, high-growth market sectors, including consumer sensors, healthcare, and data communications.

We have offices in California, Finland, Ireland, and the United Kingdom .

Some of the statements on our website or on any of our social media platforms may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally involve risks and uncertainties, and they may be subject to change without notice. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. Rockley Photonics Holdings Limited (“Rockley”) does not make any representations or warranties, express or implied, as to the accuracy, completeness, or updated status of such statements. In no case whatsoever will Rockley and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements on our website or social media platforms or for any related damages..